Imunon (CLSN) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free CLSN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 10, 2024 | morningstar.comImunon Inc IMNNMay 22, 2023 | lse.co.ukCLSN.L Regulatory NewsOctober 9, 2022 | marketscreener.comCelsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate - Marketscreener.comOctober 3, 2022 | globenewswire.comImunon Reports Partial Results from Ongoing Non-human Primate Study - GlobeNewswireOctober 3, 2022 | globenewswire.comImunon Appoints James E. Dentzer to its Board of Directors - GlobeNewswireSeptember 29, 2022 | globenewswire.comImunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4) - GlobeNewswireSeptember 28, 2022 | globenewswire.comIMUNON to Present at Chardan's 6th Annual Genetic Medicines - GlobeNewswireSeptember 19, 2022 | globenewswire.comCelsion Corporation Announces Company Name Change to Imunon, Inc. - GlobeNewswireSeptember 19, 2022 | finance.yahoo.comCelsion Corporation Announces Company Name Change to Imunon, Inc.September 15, 2022 | globenewswire.comCelsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer - GlobeNewswireSeptember 15, 2022 | finance.yahoo.comCelsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian CancerSeptember 12, 2022 | benzinga.comCelsion (NASDAQ:CLSN) – Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global I - BenzingaSeptember 12, 2022 | finance.yahoo.comCelsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13September 9, 2022 | benzinga.comCelsion (NASDAQ:CLSN) – Celsion Earnings Perspective: Return On Capital Employed - BenzingaSeptember 9, 2022 | msn.comCelsion Earnings Perspective: Return On Capital EmployedSeptember 7, 2022 | benzinga.comCelsionoration (CLSN) – Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investme - BenzingaSeptember 7, 2022 | globenewswire.comCelsion Corporation to Present at the H.C. Wainwright 24th - GlobeNewswireSeptember 7, 2022 | finance.yahoo.comCelsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 5, 2022 | reuters.comCLSN.OQ - Celsion Corporation | Stock Price & Latest News | ReutersSeptember 1, 2022 | globenewswire.comCelsion Corporation Highlights Progress in its DNA-based Vaccine Program - GlobeNewswireSeptember 1, 2022 | finance.yahoo.comCelsion Corporation Highlights Progress in its DNA-based Vaccine ProgramAugust 30, 2022 | finance.yahoo.comCLSN: Complete Enrollment of OVATION 2 Study Expected in 3Q22…August 15, 2022 | seekingalpha.comCelsion GAAP EPS of -$0.87, revenue of $0.13M - Seeking AlphaAugust 15, 2022 | marketscreener.comCELSION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) - Marketscreener.comAugust 15, 2022 | benzinga.comRecap: Celsion Q2 Earnings - BenzingaAugust 15, 2022 | globenewswire.comCelsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business Update - GlobeNewswireAugust 15, 2022 | finance.yahoo.comCelsion Corporation Reports Second Quarter 2022 Financial Results and Provides Business UpdateAugust 14, 2022 | seekingalpha.comCelsion Q2 2022 Earnings PreviewAugust 9, 2022 | globenewswire.comCelsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022 - GlobeNewswireAugust 8, 2022 | finance.yahoo.comCelsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022July 21, 2022 | nasdaq.comCelsion Appoints Corinne Le Goff To Succeed Michael Tardugno As President And CEOJuly 19, 2022 | nasdaq.comU.S. Stocks May Move Back To The Upside After Yesterday's Downturn - NasdaqJuly 19, 2022 | nasdaq.comNasdaq Bear Market: 1 Growth Stock Down More Than 90% to Buy Now - NasdaqJuly 19, 2022 | globenewswire.comCelsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer - GlobeNewswireJuly 19, 2022 | finance.yahoo.comCelsion Appoints Dr. Corinne Le Goff as President and Chief Executive OfficerJuly 19, 2022 | finance.yahoo.comCelsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)June 21, 2022 | globenewswire.comCelsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer - GlobeNewswireJune 20, 2022 | gurufocus.comCelsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates - GuruFocus.comJune 18, 2022 | benzinga.comCLSN: OVATION 2 Study 85% Enrolled… - Benzinga - BenzingaJune 14, 2022 | marketscreener.comCELSION CORP : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comJune 13, 2022 | finance.yahoo.comCLSN: OVATION 2 Study 85% Enrolled…June 9, 2022 | businesswire.comGlobal Nucleic Acid Based Gene Therapy Market to 2031 - Featuring BioMedica, Transgene and Copernicus Therapeutics Among Others - ResearchAndMarkets.com - Business WireMay 30, 2022 | finance.yahoo.comNucleic Acid Based Gene Therapy Global Market Report 2022 - Yahoo FinanceMay 20, 2022 | streetinsider.comAdvanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression - StreetInsider.comMay 17, 2022 | globenewswire.comCelsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update - GlobeNewswireMay 16, 2022 | benzinga.comCelsion: Q1 Earnings Insights - Benzinga - BenzingaMay 14, 2022 | benzinga.comEarnings Outlook For CelsionMay 14, 2022 | seekingalpha.comCelsion Q4 2022 Earnings PreviewMay 11, 2022 | streetinsider.comCelsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022 - StreetInsider.comMay 10, 2022 | globenewswire.comCelsion Corporation Highlights Pipeline Progress in Its Lead Development Candidates - GlobeNewswire Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter. Email Address How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. Click here to watch this now before it’s too late. CLSN Media Mentions By Week CLSN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLSN News Sentiment▼0.000.76▲Average Medical News Sentiment CLSN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLSN Articles This Week▼00▲CLSN Articles Average Week Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACST News Today RMTI News Today AEON News Today ANEB News Today THAR News Today KZR News Today EQ News Today EGRX News Today CASI News Today AADI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLSN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
